{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:08:57Z","timestamp":1783354137332,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>There is a growing body of evidence suggesting the decisive involvement of the human microbiome in cancer development. The consumption of antibiotics may fundamentally change the microbiome and thereby create a precancerous environment promoting cancer development and growth. However, clinical data on the association between the consumption of antibiotics and cancer incidence have remained inconclusive. In this study, we quantified the association between the intake of different antibiotics and various cancer entities among outpatients from Germany.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective case\u2013control study based on the IQVIA Disease Analyzer database included 111,828 cancer patients and 111,828 non-cancer controls who were matched to cancer cases using propensity scores. Patients were categorized as non-users, low-consumption (up to 50th percentile), and high-consumption (above 50<jats:sup>th<\/jats:sup> percentile) users of antibiotics overall and for each antibiotic class. Multivariable logistic conditional regression models were used to study the association between antibiotic intake within 5\u00a0years prior to the index date (first cancer diagnosis for cases or randomly selected date for controls) and cancer incidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The probability of cancer was significantly higher among patients with a history of antibiotic intake than in matched controls. Patients using penicillin or cephalosporins displayed a higher incidence of cancer, while the intake of tetracyclines and macrolides actually reduced the risk of cancer development slightly. A complex picture was observed in our cancer site-stratified analyses. Most notably, the consumption of penicillin was significantly and positively associated with cancer development in the respiratory organs only (low consumption OR: 1.33, 95% CI 1.20\u20131.47; high consumption OR 1.42, 95% CI 1.22\u20131.64) and cephalosporin consumption was significantly associated with respiratory organ cancer (low consumption OR: 1.32, 95% CI 1.17\u20131.48, high consumption OR: 1.47, 95% CI 1.29\u20131.66), breast cancer (high consumption OR: 1.40, 95% CI 1.25\u20131.56), and lymphoid and hematopoietic tissue cancer (high consumption OR: 1.50, 95% CI 1.35\u20131.66).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our data strongly support the hypothesis that the intake of antibiotics is positively associated with the risk of cancer development.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-022-03998-z","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T18:02:52Z","timestamp":1650391372000},"page":"1285-1293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antibiotic therapy is associated with an increased incidence of cancer"],"prefix":"10.1007","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1409-7697","authenticated-orcid":false,"given":"Christoph","family":"Roderburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven H.","family":"Loosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus S.","family":"Joerdens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcnevver","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"3998_CR1","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S0140-6736(20)31404-5","volume":"396","author":"C Abbafati","year":"2020","unstructured":"Abbafati C, Machado DB, Cislaghi B et al (2020) Five insights from the global burden of disease study 2019. Lancet 396:1135\u20131159","journal-title":"Lancet"},{"key":"3998_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9090580","volume":"9","author":"SS Amadei","year":"2020","unstructured":"Amadei SS, Notario V (2020) A significant question in cancer risk and therapy: are antibiotics positive or negative effectors? current answers and possible alternatives. Antibiotics 9:1\u201319","journal-title":"Antibiotics"},{"key":"3998_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2021-000601","author":"C Aneke-Nash","year":"2021","unstructured":"Aneke-Nash C, Yoon G, Du M, Liang P (2021) Antibiotic use and colorectal neoplasia: a systematic review and meta-analysis. BMJ Open Gastroenterol. https:\/\/doi.org\/10.1136\/bmjgast-2021-000601","journal-title":"BMJ Open Gastroenterol"},{"key":"3998_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10549-020-05675-6","volume":"182","author":"L Bach","year":"2020","unstructured":"Bach L, Kostev K, Schiffmann L, Kalder M (2020) Association between thyroid gland diseases and breast cancer: a case\u2013control study. Breast Cancer Res Treat 182:207\u2013213","journal-title":"Breast Cancer Res Treat"},{"key":"3998_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2017.01.013","volume":"106","author":"SJ Bagley","year":"2017","unstructured":"Bagley SJ, Kothari S, Aggarwal C et al (2017) Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung Cancer (Amsterdam, Netherlands) 106:1\u20137","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"key":"3998_CR6","first-page":"326","volume":"67","author":"AP Bhatt","year":"2017","unstructured":"Bhatt AP, Redinbo MR, Bultman SJ (2017) The role of the microbiome in cancer development and therapy. CA: Cancer J Clin 67:326\u2013344","journal-title":"CA: Cancer J Clin"},{"key":"3998_CR7","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1073\/pnas.1918095117","volume":"117","author":"AP Bhatt","year":"2020","unstructured":"Bhatt AP, Pellock SJ, Biernat KA et al (2020) Targeted inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy. Proc Natl Acad Sci USA 117:7374\u20137381","journal-title":"Proc Natl Acad Sci USA"},{"key":"3998_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.702414","author":"C Bi","year":"2021","unstructured":"Bi C, Xiao G, Liu C, Yan J, Chen J, Si W, Zhang J, Liu Z (2021) Molecular immune mechanism of intestinal microbiota and their metabolites in the occurrence and development of liver cancer. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.702414","journal-title":"Front Cell Dev Biol"},{"key":"3998_CR9","doi-asserted-by":"publisher","first-page":"561.e7","DOI":"10.1016\/j.cmi.2016.01.026","volume":"22","author":"R Bitterman","year":"2016","unstructured":"Bitterman R, Hussein K, Leibovici L, Carmeli Y, Paul M (2016) Systematic review of antibiotic consumption in acute care hospitals. Clin Microb Infect 22:561.e7-561.e19","journal-title":"Clin Microb Infect"},{"key":"3998_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","volume":"30","author":"J Cai","year":"2022","unstructured":"Cai J, Sun L, Gonzalez FJ (2022) Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe 30:289\u2013300","journal-title":"Cell Host Microbe"},{"key":"3998_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1159\/000518090","volume":"10","author":"KS Cheung","year":"2021","unstructured":"Cheung KS, Lam LK, Seto WK, Leung WK (2021) Use of antibiotics during immune checkpoint inhibitor treatment is associated with lower survival in hepatocellular carcinoma. Liver Cancer 10:606\u2013614","journal-title":"Liver Cancer"},{"key":"3998_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","volume":"13","author":"C de Martel","year":"2012","unstructured":"de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607\u2013615","journal-title":"Lancet Oncol"},{"key":"3998_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224848","author":"HH Farooqui","year":"2019","unstructured":"Farooqui HH, Mehta A, Selvaraj S (2019) Outpatient antibiotic prescription rate and pattern in the private sector in India: evidence from medical audit data. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0224848","journal-title":"PLoS One"},{"key":"3998_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0574-4","author":"J Fessler","year":"2019","unstructured":"Fessler J, Matson V, Gajewski TF (2019) Exploring the emerging role of the microbiome in cancer immunotherapy. J Immunother Cancer. https:\/\/doi.org\/10.1186\/s40425-019-0574-4","journal-title":"J Immunother Cancer"},{"key":"3998_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/path.5661","volume":"254","author":"P Gonz\u00e1lez-S\u00e1nchez","year":"2021","unstructured":"Gonz\u00e1lez-S\u00e1nchez P, DeNicola GM (2021) The microbiome(s) and cancer: know thy neighbor(s). J Pathol 254:332\u2013343","journal-title":"J Pathol"},{"key":"3998_CR16","first-page":"719","volume":"117","author":"Y Huber","year":"2020","unstructured":"Huber Y, Labenz C, Michel M, W\u00f6rns MA, Galle PR, Kostev K, Schattenberg JM (2020) Tumor incidence in patients with non-alcoholic fatty liver disease. Deutsches Arzteblatt Int 117:719\u2013724","journal-title":"Deutsches Arzteblatt Int"},{"key":"3998_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.725821","author":"S Ibragimova","year":"2021","unstructured":"Ibragimova S, Ramachandran R, Ali FR, Lipovich L, Ho SB (2021) Dietary patterns and associated microbiome changes that promote oncogenesis. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.725821","journal-title":"Front Cell Dev Biol"},{"key":"3998_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13030408","volume":"13","author":"L Jacob","year":"2021","unstructured":"Jacob L, Loosen SH, Kalder M, Luedde T, Roderburg C, Kostev K (2021) Impact of the COVID-19 pandemic on cancer diagnoses in general and specialized practices in Germany. Cancers 13:1\u201311","journal-title":"Cancers"},{"key":"3998_CR19","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/hep4.1541","volume":"4","author":"C Labenz","year":"2020","unstructured":"Labenz C, Huber Y, Michel M, Nagel M, Galle PR, Kostev K, Schattenberg JM (2020a) Nonalcoholic fatty liver disease increases the risk of anxiety and depression. Hepatol Commun 4:1293\u20131301","journal-title":"Hepatol Commun"},{"key":"3998_CR20","doi-asserted-by":"publisher","first-page":"e23436","DOI":"10.1097\/MD.0000000000023436","volume":"99","author":"C Labenz","year":"2020","unstructured":"Labenz C, Kostev K, Galle PR, W\u00f6rns M-A, Labenz J, Tanislav C, Adarkwah CC (2020) Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis. Medicine 99:e23436","journal-title":"Medicine"},{"key":"3998_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26444\/aaem\/94299","volume":"26","author":"AM Lewandowska","year":"2019","unstructured":"Lewandowska AM, Rudzki M, Rudzki S, Lewandowski T, Laskowska B (2019) Environmental risk factors for cancer\u2014review paper. Ann Agric Env Med 26:1\u20137","journal-title":"Ann Agric Env Med"},{"key":"3998_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03867-1","author":"SH Loosen","year":"2021","unstructured":"Loosen SH, Kostev K, Luedde M, Luedde T, Roderburg C (2021) Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-021-03867-1","journal-title":"J Cancer Res Clin Oncol"},{"key":"3998_CR23","first-page":"1106","volume":"14","author":"MS Martins Lopes","year":"2020","unstructured":"Martins Lopes MS, Machado LM, Ismael Amaral Silva PA et al (2020) Antibiotics, cancer risk and oncologic treatment efficacy: a practical review of the literature. Ecancermedicalscience 14:1106","journal-title":"Ecancermedicalscience"},{"key":"3998_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.trecan.2019.12.007","volume":"6","author":"AG Ram\u00edrez-Labrada","year":"2020","unstructured":"Ram\u00edrez-Labrada AG, Isla D, Artal A, Arias M, Rezusta A, Pardo J, G\u00e1lvez EM (2020) The influence of lung microbiota on lung carcinogenesis, immunity, and immunotherapy. Trends Cancer 6:86\u201397","journal-title":"Trends Cancer"},{"key":"3998_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5414\/CP203320","volume":"56","author":"W Rathmann","year":"2018","unstructured":"Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K (2018) Basic characteristics and representativeness of the German disease analyzer database. Int J Clin Pharm Ther 56:459\u2013466","journal-title":"Int J Clin Pharm Ther"},{"key":"3998_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00432-018-2816-0","volume":"145","author":"MH Raza","year":"2019","unstructured":"Raza MH, Gul K, Arshad A et al (2019) Microbiota in cancer development and treatment. J Cancer Res Clin Oncol 145:49\u201363","journal-title":"J Cancer Res Clin Oncol"},{"key":"3998_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03861-7","author":"C Roderburg","year":"2021","unstructured":"Roderburg C, Loosen SH, Hoyer L, Luedde T, Kostev K (2021) Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-021-03861-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"3998_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0140-6736(17)30566-4","volume":"390","author":"G Rook","year":"2017","unstructured":"Rook G, B\u00e4ckhed F, Levin BR, McFall-Ngai MJ, McLean AR (2017) Evolution, human-microbe interactions, and life history plasticity. Lancet 390:521\u2013530","journal-title":"Lancet"},{"key":"3998_CR29","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1002\/cncr.33030","volume":"126","author":"SJ Rotz","year":"2020","unstructured":"Rotz SJ, Dandoy CE (2020) The microbiome in pediatric oncology. Cancer 126:3629\u20133637","journal-title":"Cancer"},{"key":"3998_CR30","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nrc3610","volume":"13","author":"RF Schwabe","year":"2013","unstructured":"Schwabe RF, Jobin C (2013) The microbiome and cancer. Nat Rev Cancer 13:800\u2013812","journal-title":"Nat Rev Cancer"},{"key":"3998_CR31","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41416-020-01082-2","volume":"123","author":"J Simin","year":"2020","unstructured":"Simin J, Fornes R, Liu Q, Olsen RS, Callens S, Engstrand L, Brusselaers N (2020) Antibiotic use and risk of colorectal cancer: a systematic review and dose\u2013response meta-analysis. Br J Cancer 123:1825\u20131832","journal-title":"Br J Cancer"},{"key":"3998_CR32","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA: Cancer J Clin 71:209\u2013249","journal-title":"CA: Cancer J Clin"},{"key":"3998_CR33","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.2217\/fon-2021-0087","volume":"17","author":"JN Wertman","year":"2021","unstructured":"Wertman JN, Dunn KA, Kulkarni K (2021) The impact of the host intestinal microbiome on carcinogenesis and the response to chemotherapy. Future Oncol 17:4371\u20134387","journal-title":"Future Oncol"},{"key":"3998_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05467-z","author":"S Wu","year":"2018","unstructured":"Wu S, Zhu W, Thompson P, Hannun YA (2018) Evaluating intrinsic and non-intrinsic cancer risk factors. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-018-05467-z","journal-title":"Nat Commun"},{"key":"3998_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08664-0","author":"ZK Yu","year":"2021","unstructured":"Yu ZK, Xie RL, You R, Liu YP, Chen XY, Chen MY, Huang PY (2021) The role of the bacterial microbiome in the treatment of cancer. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-021-08664-0","journal-title":"BMC Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-03998-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-03998-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-03998-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T10:13:00Z","timestamp":1677838380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-03998-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3998"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-03998-z","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"24 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}